F. Journe et al., RENAL EPIDERMAL GROWTH-FACTOR PRECURSOR - PROTEOLYTIC PROCESSING IN AN IN-VITRO CELL-FREE SYSTEM, Biochimica et biophysica acta. Molecular cell research, 1357(1), 1997, pp. 18-30
The enzymatic processing of the membrane-bound renal epidermal growth
factor precursor (proEGF) could be an important step in the control of
nephrogenic repair consecutive to kidney insult. The enzyme machinery
responsible for that processing was examined in a cell-free system co
nsisting of renal membranes isolated from kidney homogenates by differ
ential centrifugation, and incubated in vitro. After a 24-h incubation
at 37 degrees C, 6-14% of membrane-bound proEGF was processed and sol
uble products with EGF immunoreactivity were released. As revealed by
HPLC and Western blotting analysis, the products of proEGF proteolysis
consisted of 6 kDa EGF (the molecular weight of mature EGF) and two p
olypeptides with molecular weights around 45 kDa. Interestingly the 45
kDa EGF forms, like the 6 kDa EGF, exhibited mitogenic activity towar
d growth-arrested NRK-52E renal cell line. The kinetic study of proEGF
degradation gave data consistent with the 45 kDa product(s) being pro
cessing intermediate(s) between proEGF and 6 kDa EGF. The enzymatic ac
tivity responsible for proEGF nicking was inhibited by divalent heavy
metal ions (Cu2+ Or Zn2+) and several protease inhibitors (aprotinin,
PMSF, leupeptin, soybean trypsin inhibitor), suggesting that proEGF is
processed by kallikrein-like serine proteases present in the membrane
preparations. Along with previous studies, the current observations s
uggest that renal kallikreins might play a role in renal tubular regen
eration by promoting the release of soluble EGF in renal tissue.